Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Thursday
Aug 28th
Home arrow Farmavita.Net Journal arrow Intellectual Property
Farmavita.Net - Intellectual Property
Croatia_Dugi_Otok

This section is about issues of intellectual property in pharmaceutical industry.

Contributions from members are very welcome. Every article is published with full credentials of Author. Please  Register as the member and submit your article.



Print E-mail
Intellectual Propriatery News
Written by Jesse Tale   
Friday, 11 July 2008

genericsweb.gif

Accurate and complete expiry information now available with GenericsWeb Pipeline Scope

Finally, the generics industry has fast access to reliable key patent, SPC and data protection expiry information. Pipeline Scope, the latest release from industry experts GenericsWeb provides accurate and complete data for over 1400 INNs, across 37 countries, delivered through an interface that is easy to use and interpret.


Read more...
 
Print E-mail
Intellectual Propriatery News
Written by Administrator   
Wednesday, 30 April 2008

FDA Announces Measures to Improve Generic Drug Access

The Food and Drug Administration (FDA) im March 2004 announced that it will provide more information to the public to help generic drug applicants determine if they are eligible for 180-day marketing exclusivity for their products. This period of marketing exclusivity is generally provided to the first generic drug that challenges a patent for the innovator product.

Read more...
 
Print E-mail
Intellectual Propriatery News
Written by Miguel Gorjão-Henriques   
Tuesday, 29 April 2008

 Pirates and Corsairs - The difficult equation Pharma-Parallel Trade

“In the legal debate (…), with a little bit of imagination, the undertakings who dedicate themselves to parallel trade could be compared with the pirates and those who defend their intellectual property rights could be compared with the corsairs, who received the “corsair patent” from their Government to attack the ships of the enemy countries.

Read more...
 
Print E-mail
Intellectual Propriatery News
Written by Peter Wittner   
Wednesday, 22 August 2007

ic_logo_.gifThe continuing battle over Atorvastatin (Lipitor®)

In 2006, Pfizer’s product Lipitor (Atorvastatin) attained sales of US$ 11.7 billion. This was down by 3.6% from the figure for 2005, which disappointed Pfizer but still left it with enough turnover to make it a very attractive target for generic copies.

Read more...
 
Print E-mail
Intellectual Propriatery News
Written by Peter Wittner   
Friday, 13 July 2007

Biosimilars – inflated expectations?

ic_logo_In October 2006, Senators Waxman, Schumer and Clinton introduced the “Access to Life-Saving Medicines Act” to the US Congress in an attempt to establish an abbreviated application process for biological products.

It was the same Senator Waxman who cooperated in 1984 with Senator Hatch to introduce what became known as the Hatch-Waxman Act to introduce a simplified method of registration for generics.

Read more...
 
Print E-mail
Intellectual Propriatery News
Written by Administrator   
Friday, 04 May 2007

 STN Logo

World's largest patent database is now online

More than 63 million patent documents from 80 patent organisations worldwide can be searched via the International Patent Documentation Data Base, (INPADOCDB). It was created by merging and revising two existing databases of the European Patent Office (EPO).

Read more...
 
Print E-mail
Intellectual Propriatery News
Written by Sanjay J Daharwal   
Thursday, 12 April 2007

farmavitanet_logo

Novel Approches about Semisolid Dosage Forms  

The new access in semisolid dosage forms by adding or applying some new approaches to improve them from bioavailability, efficacy, drug dosing  cost etc and  also techniques which may be launched recently, but not widely used.  

Read more...
 
Print E-mail
Intellectual Propriatery News
Written by Jesse Tale   
Friday, 23 March 2007

Vardenafil (Levitra®) - Opportunity for Proactive Generic Companies?

The recently released GenericsWeb Pipeline Developer patent report for Vardenafil  (Levitra®) highlights the importance of high quality patent information when considering development of generic equivalents in the early stages of a product’s life cycle.

Read more...
 
Print E-mail
Intellectual Propriatery News
Written by Administrator   
Tuesday, 20 February 2007

 BioMed

Closing the access gap for health innovations: an open licensing proposal for universities

This article centers around a proposal outlining how research universities could leverage their intellectual property to help close the access gap for health innovations in poor countries. A recent deal between Emory University, Gilead Sciences, and Royalty Pharma is used as an example to illustrate how 'equitable access licensing' could be put into practice.

Read more...
 
<< Start < Prev 1 2 Next > End >>

Results 1 - 9 of 18
Advertisement

Featured Video

Did you know? Global Shift Happens! 

This outstanding presantation will make you think about global economy and coming global changes. 

Login to Farmavita.Net

membership is FREE

BabelFish Translator




Click Flag for Translation

Who's Online

We have 3 guests online

Tag Clouds

Joomla Modul

Farmavita.Net RSS News


Products

Click to Products

News

Click to News

Reports

Click to Reports

Events

Click to Events

CRAMS

Click to CRAMS